Savara Pharmaceuticals
SVRA
#6600
Rank
โ‚น46.74 B
Marketcap
โ‚น272.36
Share price
-1.54%
Change (1 day)
-31.49%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น3.35 Billion

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น3.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น3.09 B16.93%
2022-12-31โ‚น2.64 B10.83%
2021-12-31โ‚น2.38 B-2.08%
2020-12-31โ‚น2.43 B-0.84%
2019-12-31โ‚น2.46 B-20.15%
2018-12-31โ‚น3.08 B19.69%
2017-12-31โ‚น2.57 B-41.55%
2016-12-31โ‚น4.40 B118.52%
2015-12-31โ‚น2.01 B168.54%
2014-12-31โ‚น0.75 B63.24%
2013-12-31โ‚น0.45 B62.12%
2012-12-31โ‚น0.28 B5.57%
2011-12-31โ‚น0.26 B232.76%
2010-12-31โ‚น80.72 M-26.08%
2009-12-31โ‚น0.10 B-51.8%
2008-12-31โ‚น0.22 B64.62%
2007-12-31โ‚น0.13 B25.09%
2006-12-31โ‚น0.11 B-92.23%
2005-12-31โ‚น1.41 B2582.14%
2004-12-31โ‚น52.76 M610.82%
2003-12-31โ‚น7.42 M-84.25%
2002-12-31โ‚น47.14 M6.6%
2001-12-31โ‚น44.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น1.03 B-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น72.57 B 2,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA